Navigation Links
ProteomeLab PF 2D Protein Fractionation System from Beckman Coulter

ProductsProteomeLab PF 2D Protein Fractionation System from Beckman Coulter
Company Beckman Coulter
Item ProteomeLab PF 2D Protein Fractionation System
Description The ProteomeLab PF 2D is an automated, two-dimensional fractionation system for high-resolution analysis of complex protein mixtures. Part of Beckman Coulters ProteomeLab family of products, the PF 2D produces results in just hours. The system effectively resolves the thousands of proteins present in cell lysates, addressing a key challenge in todays proteomics research.In the first dimension, chromatofocusing separates the proteins according to their pI, providing information that can be related to traditional isoelectric focusing techniques. Fractions from the first dimension are collected and automatically injected into a second dimension, which separates on the basis of hydrophobicity. ProteomeLab PF 2D software displays both one-and two-dimensional maps of the expressed protein profiles in easy-to-read formats. This in solution approach delivers liquid fractions for further study.The PF 2D system addresses many of the problems associated with traditional proteomics research, such as detection of low abundance proteins, run-to-run reproducibility, quantitation, detection of membrane or hydrophobic proteins, detection of basic proteins and detection of very low and very high molecular weight proteins. The automated system also requires less time and manpower than traditional, labor-intensive techniques.
Info Beckman CoulterBeckman Coulter
4300 N. Harbor Boulevard
PO Box 3100
Fullerton, CA 92834-3100
Customer Service: (800) 742-2345
Fax Number: (800) 643-4366
Web Site:
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. ProteomeLab PA 800 Protein Characterization System from Beckman Coulter
2. Mouse Anti-Protein S Monoclonal Antibody, Unconjugated, Clone HYB 232-02 from Abcam
3. S-Protein Agarose from Novagen
4. Rabbit Anti-Human Vitamin K-dependent Protein S (PROS1) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
5. S-Protein Agarose from Novagen
6. S-Protein Agarose from Novagen
7. Standard Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences
8. Protein 295 ex from HORIBA Jobin Yvon
9. Protein Kinase Substrate (PKS) Peptide Microarray - Comprehensive Service from LC Sciences
10. Imaging Mass Spectrometry for Small Molecule Localization from Protein Discovery, Inc.
11. ProteinPilot Software from Applied Biosystems
COMING SOON: Anti-Mouse C5/C5b, Clone BB5.1. Monoclonal Antibody...
Vesicle Associated Membrane Protein (VAMP 1/2)...
synphilin-1 (V-19)...
Rabbit polyclonal to Presenilin 1, prediluted ( Abpromise for all tested applications). entrezGeneID: 5663 SwissProtID: P49768...
Biology Products:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
(Date:11/24/2015)... Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders ... Israel time, at the law offices of Goldfarb Seligman ... Floor, Tel Aviv, Israel . ... to the Board of Directors; , election of Liat ... an amendment to certain terms of options granted to our Chief Executive ...
Breaking Biology Technology: